Stockreport

A Decade of Data Shows the Value of Isoray’s Cesium-131 As Prostate Cancer Internal Radiation Therapy Treatment

IsoRay, Inc. (DE)  (ISR) 
NASDAQ:AMEX Investor Relations: isoray.com
PDF Overall Ten-Year Biochemical Success Rate for Entire Group Was 96.2%Largest and Longest Followed Series of Cesium-131 Treated Patients Reported to Date RICHLAND, Wash [Read more]